KALA BIO, Inc. (KALA) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "KALA"
      ],
      "issuer_cik": "0001479419",
      "owner_cik": "0001605767",
      "accession_number": "0001605767-25-000004",
      "form_type": "4",
      "filing_date": "2025-10-24",
      "period_of_report": "2025-10-22",
      "issuer_name": "KALA BIO, Inc.",
      "issuer_trading_symbol": "KALA",
      "owner_name": "Bazemore Todd",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 47768,
      "transaction_price_per_share": 0.83,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 35932,
      "transaction_value": 39647.439999999995,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."
        },
        {
          "id": "F2",
          "description": "Includes 35,732 unvested RSUs."
        }
      ]
    },
    {
      "tickers": [
        "KALA"
      ],
      "issuer_cik": "0001479419",
      "owner_cik": "0001710969",
      "accession_number": "0001710969-25-000003",
      "form_type": "4",
      "filing_date": "2025-10-24",
      "period_of_report": "2025-10-22",
      "issuer_name": "KALA BIO, Inc.",
      "issuer_trading_symbol": "KALA",
      "owner_name": "Reumuth Mary",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "CHIEF FINANCIAL OFFICER",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 32230,
      "transaction_price_per_share": 0.83,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 29873,
      "transaction_value": 26750.899999999998,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."
        },
        {
          "id": "F2",
          "description": "Includes 28,906 unvested RSUs."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.